You just read:

FDA Approves One-Pill, Once-Daily Viramune® XR™ (nevirapine) Extended-Release Tablets for Use in Combination With Other Antiretroviral Agents for Treatment of HIV-1 Infection in Adults

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

Apr 04, 2011, 05:38 ET